Module A — Discovery, data & guardrails for pharma
Frame where Google Cloud changes regulated and operational workflows in pharma before scaling beyond pilots. Target outcome: Drug discovery timeline reduction (2-3 years saved).
session outline
- Stakeholder map: sponsors, risk, and practitioners who own Google Cloud outcomes in your org.
- Data boundary & classification: what can flow into models vs. what stays offline—using pharma-specific examples (e.g., Drug discovery and molecule optimization (reducing discovery time by 30-40%)).
- Compliance checkpoints: FDA regulatory requirements for AI in drug development, GxP (Good Practice) compliance standards requirements for pharma.
- Acceptable use, logging, and escalation when outputs inform customer or patient-facing decisions.
- Pilot scorecard: hypothesis, baseline, success metrics (targeting: Drug discovery timeline reduction (2-3 years saved)), and kill criteria.
labs
- Facilitated triage: three candidate Google Cloud use cases scored on feasibility × impact × risk for pharma. Reference cases: Drug discovery and molecule optimization (reducing discovery time by 30-40%); Clinical trial patient matching and recruitment.
- Compliance red-team: how FDA regulatory requirements for AI in drug development would challenge each brief (structure only—not legal advice).
beyond-catalog topics (custom)
- Procurement-ready comparison criteria when evaluating Google Cloud vendors for pharma use cases.
- Region-specific regulatory touchpoints: FDA regulatory requirements for AI in drug development, GxP (Good Practice) compliance standards for multi-country operations.